Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters

Cellular and Molecular Life Sciences

Volumn 59, Issue 2, 2002, Pages 307-322

  Di Pietro, A ^a   Conseil, G ^a,b   Perez Victoria J M ^c   Dayan, G ^a,d   Baubichon Cortay, H ^a   Trompier, D ^a   Steinfels, E ^a   Jault, J M ^a   De Wet, H ^e   Maitrejean, M ^a   Comte, G ^a   Boumendjel, A ^f   Mariotte, A M ^f   Dumontet, C ^g   McIntosh, D B ^e   Goffeau, A ^h   Castanys, S ^c   Gamarro, F ^c   Barron, D ^a  

^a UNIVERSITÉ LYON 1   (France)

^b QUEEN S UNIVERSITY   (Canada)

^c INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f Laboratoire de Pharmacochimie   (France)

^g INSERM   (France)

^h UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

ABC transporters; Cancer cells; Flavonoids; Leishmania; Modulators; Multidrug resistance (MDR); P glycoprotein; Yeast

Indexed keywords

ABC TRANSPORTER; CYTOTOXIC AGENT; FLAVONOID; GLYCOPROTEIN P;

BINDING AFFINITY; CELL GROWTH; CELL TRANSPORT; DRUG BINDING; DRUG INHIBITION; FLOW CYTOMETRY; LEISHMANIA; MULTIDRUG RESISTANCE; PLASMODIUM FALCIPARUM; PROTEIN EXPRESSION; REVIEW; SACCHAROMYCES CEREVISIAE; YEAST;

PLASMODIUM FALCIPARUM; PROTOZOA; SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 18244376403     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-002-8424-8     Document Type: Review

References (128)

1. Cell biological mechanisms of multidrug resistance in tumors
2. The biology of the P-glycoprotein
3. The biochemistry of P-glycoprotein-mediated multidrug resistance
4. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
5. The multidrug resistance protein family
6. A multidrug resistance transporter from human MCF-7 breast cancer cells
7. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistance cells: Demonstration of homology to ABC transport genes
8. Biochemistry of multidrug resistance mediated by the multidrug transporter
9. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine
10. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites
11. The mouse multidrug resistance gene family: Structural and functional analysis
12. Transmembrane organization of mouse P-glycoprotein determined by epitope insertion and immunofluorescence
13. Distantly related sequences in the alpha- and beta-subunits of ATPsynthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide-binding fold
14. Traffic ATPases: A superfamily of transport proteins operating from Escherichia coli to humans
15. ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans
16. Structural biology of Rad50 ATPase: ATP-driven conformational control in DNA double-strand break repair and the ABC-ATPase superfamily
17. Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis
18. Crystal structure of the ATP-binding subunit of an ABC transporter
19. Crystal structure of Ma1K, the ATPase subunit of the trehelose/maltose ABC transporter of the archeon Thermococcus litoralis
20. P-glycoprotein shows strong catalytic cooperativity between the two nucleotide sites
21. Correlation between steady-state ATP hydrolysis and vanadate-induced ADP trapping in human P-glycoprotein. Evidence for ADP release as the rate-limiting step in the catalytic cycle and its modulation by substrates
22. P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site
23. Photoaffinity labelling of P-glycoprotein catalytic sites
24. The nitrogen of the acetamido group of colchicine modulates P-glycoprotein-mediated multidrug resistance
25. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities
26. The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism
27. Mechanisms of multidrug transporters
28. Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter
29. Is the multidrug transporter a flippase?
30. Phosphatidylcholine translocase: A physiological role for the mdr2 gene
31. Biochemical, cellular and pharmacological aspects of the multidrug transporter
32. Identification of drug interaction sites in P-glycoprotein
33. Identification of the drug-binding site of human P-glycoprotein using a thiol-reactive substrate
34. Kinetics of the multidrug transporter (P-glycoprotein) and its reversal
35. Involvement of an ABC transporter in a developmental pathway regulating hypocotyl cell elongation in the light
36. Pgh1 modulates sensitivity and resistance to multiple antimalarials
37. Molecular characterization of the ldmdr1 multidrug resistance gene from Leishmania donovani
38. Altered drug membrane permeability in a multidrug-resistant Leishmania tropica line
39. A bacterial antibiotic-resistance gene that complements the human multidrug-resistance P-glycoprotein gene
40. Antibiotic specificity resistance: Era of the multidrug pump
41. The ABC family of multidrug transporters in microorganisms
42. Complete inventory of the yeast ABC proteins
43. Fungal ABC proteins: Pleitropic drug resistance, stress response and cellular detoxification
44. The pleiotropic drug ABC transporters from Saccharomyces cerevisiae
45. PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1
46. Molecular cloning and expression of the Saccharomyces cerevisiae STS1 gene product. A yeast ABC transporter conferring mycotoxin resistance
47. Identification and characterization of Snq2, a new multidrug ATP binding cassette transporter of the yeast plasma membrane
48. The ATP binding cassette transporters Pdr5p and Snq2 of Saccharomyces cerevisiae can mediate transport of steroids in vivo
49. Anticancer drugs, ionophoric peptides and steroids as substrates of the yeast multidrug transporter Pdr5p
50. Molecular and phenotypic characterization of yeast PDR1 mutants that show hyperactive transcription of various ABC multidrug transporter genes
51. The transmembrane domain 10 of the yeast Pdr5p ABC antifungal efflux pump determines both substrate specificity and inhibitor susceptibility
52. Molecular cloning and characterization of a novel gene of Candida albicans, CDRI, conferring multiple resistance to drugs and antifungals
53. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: Characterization of CDR2, a new multidrug ABC transporter gene
54. Pharmacologic approaches to reversing multidrug resistance
55. Physiological-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells
56. Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance
57. Structural characteristics of compounds that modulate P-glycoprotein-associated multidrug resistance
58. Structural determinants of phenoxazine type compounds required to modulate the accumulation of vinblastine and vincristine in multidrug-resistant cell lines
59. Structure-activity relationship of verapamil analogs and reversal of multidrug resistance
60. Characterization of prenylcysteines that interact with P-glycoprotein and inhibit drug transport in tumor cells
61. Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance
62. Comparison of staurosporine and four analogues: Their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells
63. Protein kinase C effectors bind to multidrug ABC transporters and inhibit their activity
64. Interaction of bioactive hydrophobic peptides with the human multidrug transporter
65. Synthestic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport
66. P-glycoprotein substrates and antagonists cluster into two distinct groups
67. A general pattern for substrate recognition by P-glycoprotein
68. Steroid transport, accumulation and antagonism of P-glycoprotein in multidrug-resistant cells
69. Reversal of multidrug resistance by RU 486
70. The antiprogestatin drug RU486 potentiates doxorubicin cytotoxicity in multidrug resistant cells through inhibition of P-glycoprotein function
71. Interaction of tamoxifen with the multidrug resistance P-glycoprotein
72. Malignant endometrial polyps in post-menopausal breast cancer tamoxifen-treated patients
73. Advances in flavonoid research since 1992
74. Isoprenylated flavonoids-a survey
75. Uses and properties of Citrus flavonoids
76. Dietary intake and bioavailability of polyphenols
77. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease and cancer
78. Effect of synthetic and naturally occurring chalcones on ovarian cancer cell growth: Structure-activity relationships
79. Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine protein kinases
80. Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase
81. Genistein, a specific inhibitor of tyrosine-specific protein kinases
82. Crystal structure of the Src family tyrosine kinase Hck
83. Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: Evidence for distinct drug interaction domains on topoisomerase II
84. Interaction of flavonoid compounds with contractile proteins of skeletal muscle
85. Pig heart mitochondrial ATPase: Properties of purified and membrane-bound enzyme
86. +-ATPase: Aspects of the structure-activity relationship and action mechanism
87. 2+ pump. Kinetics and structure-function relationships
88. +-ATPase by flavonoids: A structure-activity study
89. Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers
90. Modulation of adriamycin in accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism
91. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target
92. Effects of flavonols on P-glycoprotein activity in cultured rat hepatocytes
93. Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein
94. Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein
95. Overexpression and purification of the carboxyl-terminal nucleotide-binding domain from mouse P-glycoprotein. Strategic location of a tryptophan residue
96. Flavonoids: A class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein Proc
97. Correlation between the affinity of flavonoids binding to cytosolic site of Leishmania tropica multidrug transporter and their efficiency to revert parasite resistance to daunomycin
98. The flavanolignan silybin and its hemisynthetic derivatives, a novel series of potential modulators of P-glycoprotein
99. Halogenated chalcones with high-affinity binding to P-glycoprotein: Potential modulators of multidrug resistance
100. Synthesis and biological activity of 4-alkoxy chalcones: Potential hydrophobic modulators of P-glycoprotein-mediated multidrug resistance
101. C-isoprenylation of flavonoids enhances binding affinity towards P-glycoprotein and modulation of cancer cell chemoresistance
102. B-ring substituted 5,7-dihydroxyflavonols with high-affinity binding to P-glycoprotein responsible for cell multidrug resistance
103. Organolithium-mediated synthesis of prenylchalcones as potential inhibitors of chemoresistance
104. Prenylated xanthones as potential P-glycoprotein modulators
105. Recombinant N-terminal nucleotide-binding domain from mouse P-glycoprotein: Over-expression, purification and role of cysteine-430
106. Binding of steroid modulators to recombinant cytosolic domain from mouse P-glycoprotein in close proximity to the ATP site
107. High-affinity binding of silybin derivatives to the nucleotide-binding domain of a Leishmania tropica P-glycoprotein-like transporter and chemosensitization of a multidrug resistant parasite to daunomycin
108. Prenyl flavonoids as potent inhibitors of the Pdr5p multidrug ABC transporter from Saccharomyces cerevisiae
109. 2′,3′-O-(2,4,6-trinitrophenyl)-8-azido-AMP and -ATP photolabel Lys-492 at the active site of sarcoplasmic reticulum Ca(2+)-ATPase
110. Sequence requirements of the ATP-binding site within the C-terminal nucleotide-binding domain of mouse P-glycoprotein: Structure-activity relationships for flavonoid binding
111. Specific inhibition of cyclic AMP-dependent protein kinase by waranglone and robustic acid
112. Flavonoid-related modulators of multidrug resistance: Synthesis, pharmacological activity and structure-activity relationships
113. Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption
114. The pharmacological role of P-glycoprotein in the intestinal epithelium
115. Is the role of the small intestine in first-pass metabolism overemphasized?
116. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy
117. Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells
118. Influence of dietary components on the gastrointestinal metabolism and transport of drugs
119. The fate of naringin in humans: A key to grapefruit juice-drug interactions?
120. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit components in Caco-2 cells
121. Grapefruit juice activates P-glycoprotein-mediated drug transport
122. 6′,7′-Dihydroxybergamottin in grapefruit juice and Seville orange juice: Effects on cyclosporin disposition, enterocyte CYP3A4 and P-glycoprotein
123. Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities
124. Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4